Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1996 1
1999 1
2007 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava.
Cananzi FC, Mussi C, Bordoni MG, Marrari A, De Sanctis R, Colombo P, Quagliuolo V. Cananzi FC, et al. J Surg Oncol. 2016 Jul;114(1):44-9. doi: 10.1002/jso.24244. Epub 2016 Apr 6. J Surg Oncol. 2016. PMID: 27062161
Nine patients developed distant relapse, two of them concomitant local recurrence; no exclusive local recurrence was observed. The 3- and 5-year distant recurrence free survival were 30% and 10%, respectively. ...
Nine patients developed distant relapse, two of them concomitant local recurrence; no exclusive local recurrence was observed. The 3- …
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
McMeekin DS, Sill MW, Darcy KM, Stearns-Kurosawa DJ, Webster K, Waggoner S, Benbrook D. McMeekin DS, et al. Gynecol Oncol. 2007 Sep;106(3):596-603. doi: 10.1016/j.ygyno.2007.05.013. Epub 2007 Jun 27. Gynecol Oncol. 2007. PMID: 17597196 Clinical Trial.
OBJECTIVES: To evaluate the efficacy and adverse events (AEs) of thalidomide in previously treated, measurable, persistent or recurrent leiomyosarcoma (LMS) of the uterus, and to explore associations between angiogenic markers and treatment or clinical outcome. ...M …
OBJECTIVES: To evaluate the efficacy and adverse events (AEs) of thalidomide in previously treated, measurable, persistent or recurrent …
Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
Thigpen T, Blessing JA, Yordan E, Valea F, Vaccarello L. Thigpen T, et al. Gynecol Oncol. 1996 Oct;63(1):120-2. doi: 10.1006/gyno.1996.0289. Gynecol Oncol. 1996. PMID: 8898180 Clinical Trial.
Twenty-eight patients with advanced, persistent or recurrent leiomyosarcoma of the uterus not previously exposed to cytotoxic drugs were entered into a study of single-agent intravenous etoposide 100 mg/m2 daily for 3 days every 3 weeks. No complete or partial respo …
Twenty-eight patients with advanced, persistent or recurrent leiomyosarcoma of the uterus not previously exposed to cytotoxic …
Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
Sutton GP, Blessing JA, Barrett RJ, McGehee R. Sutton GP, et al. Am J Obstet Gynecol. 1992 Feb;166(2):556-9. doi: 10.1016/0002-9378(92)91671-v. Am J Obstet Gynecol. 1992. PMID: 1536229
OBJECTIVE: The purpose of this study was to evaluate the activity of ifosfamide (isophosphamide) in patients with advanced or recurrent leiomyosarcoma not previously exposed to chemotherapy. STUDY DESIGN: This is a phase II groupwide study of the Gynecologic Oncolog …
OBJECTIVE: The purpose of this study was to evaluate the activity of ifosfamide (isophosphamide) in patients with advanced or recurrent …
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
Slayton RE, Blessing JA, Look K, Anderson B. Slayton RE, et al. Invest New Drugs. 1991 May;9(2):207-8. doi: 10.1007/BF00175091. Invest New Drugs. 1991. PMID: 1874603 Clinical Trial.
Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for leiomyosarcoma of the uterus at the dose and schedule tested....
Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for leiomyo …
Benefits of endorectal ultrasound for management of smooth-muscle tumor of the rectum: report of three cases.
Hsieh JS, Huang CJ, Wang JY, Huang TJ. Hsieh JS, et al. Dis Colon Rectum. 1999 Aug;42(8):1085-8. doi: 10.1007/BF02236709. Dis Colon Rectum. 1999. PMID: 10458136
Their histologic types were leiomyoma and leiomyosarcoma. The third patient had a recurrent leiomyosarcoma. Proctosigmoidoscopy found a linear lesion with ulcerated mucosa on the rectal wall. Endorectal ultrasound observed a hypoechoic solid tumor of 3.5 cm x …
Their histologic types were leiomyoma and leiomyosarcoma. The third patient had a recurrent leiomyosarcoma. Proctosigmoidoscop …